ArticleMultiple sclerosis journal - experimental, translational and clinical
Sex-dependent bioactive lipid mediator profiles in multiple sclerosis.
Article in Multiple sclerosis journal - experimental, translational and clinical. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pathophysiological drivers of sex differences in multiple sclerosis (MS) remain unclear. Potential candidates include bioactive lipid mediators (LMs), which are pivotal regulators of neuro-inflammatory responses. Objective: To investigate sex-dependent LM differences in MS. Methods: Plasma lipids were measured using targeted HPLC-MS/MS in a birth-year MS cohort (N = 410; n = 285 MS, n = 169 RRMS, n = 80 SPMS and n = 36 PPMS). Lipid profiles were compared between sexes and correlated with disability (Expanded Disability Status Scale (EDSS)), neuroaxonal damage (neurofilament light, NfL), whole brain volume (WBV) and T2 lesion volume (LV). Results: In healthy controls, 9-HOTrE levels were higher in women than men. In individuals with MS, women had higher 9-HOTrE, 18-HEPE and 9-HODE levels than men, while men had higher 15-HEPE, 17-HDHA and 11,12-DiHET levels than women. Among these LMs, increased 11,12-DiHET levels were associated with higher EDSS and NfL levels, while higher levels of the remaining LMs, such as 9-HOTrE, were associated with lower EDSS and lower LV. Conclusion: These findings provide insights into potential sex-dependent lipid-mediated pathophysiological mechanisms in MS patients. Our findings suggest that certain LMs, such as 9-HOTrE, may display neuroprotective effects in MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.